Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, Basel CH-4070, Switzerland.
J Pharm Biomed Anal. 2025 Jan 1;252:116499. doi: 10.1016/j.jpba.2024.116499. Epub 2024 Oct 9.
The incorporation of intramolecular hydrogen bonds (IMHB) into small molecules constitutes an interesting optimization strategy to afford potential drug candidates with enhanced solubility as well as permeability and consequently improved bioavailability (if metabolic stability is high). Common methods to assess IMHB rely on spectroscopic or diffraction techniques, which, however, have limited throughput when screening for hit compounds in early phases of drug discovery. Inspired by literature findings using supercritical fluid chromatography (SFC) as an indirect method for IMHB identification in a screening context, we aimed at developing a secondary chromatographic methodology taking advantage of commonly used HPLC-MS instrumentation. In this work, we explored hydrophilic interaction liquid chromatography (HILIC) and developed a method for discriminating compounds based on their hydrogen bonding features. By quantifying retention of different matched molecular pairs (MMP) and using information about their low energy conformations from quantum-mechanical calculations, we defined a hydrogen bonding-driven adsorption (k) chromatographic parameter to assess a compound's propensity to forming IMHB. In addition to the MMP analysis, we found that the k parameter allows for the differentiation of analytes forming IMHB regardless of the comparison with control compounds.
将分子内氢键(IMHB)纳入小分子中,是一种有趣的优化策略,可以提高候选药物的溶解度、通透性,进而提高生物利用度(如果代谢稳定性高的话)。评估 IMHB 的常用方法依赖于光谱或衍射技术,但在药物发现的早期阶段筛选命中化合物时,这些方法的通量有限。受文献中使用超临界流体色谱(SFC)作为筛选环境中识别 IMHB 的间接方法的启发,我们旨在开发一种利用常用的 HPLC-MS 仪器的二次色谱方法。在这项工作中,我们探索了亲水相互作用液相色谱(HILIC),并开发了一种基于化合物氢键特征进行区分的方法。通过量化不同匹配分子对(MMP)的保留时间,并利用量子力学计算得出的关于它们低能构象的信息,我们定义了一个氢键驱动吸附(k)色谱参数,以评估化合物形成 IMHB 的倾向。除了 MMP 分析,我们还发现 k 参数允许区分形成 IMHB 的分析物,而无需与对照化合物进行比较。